RU2745844C2 - Нанокапсулы жирорастворимого активного ингредиента, их производство и виды применения - Google Patents

Нанокапсулы жирорастворимого активного ингредиента, их производство и виды применения Download PDF

Info

Publication number
RU2745844C2
RU2745844C2 RU2018135575A RU2018135575A RU2745844C2 RU 2745844 C2 RU2745844 C2 RU 2745844C2 RU 2018135575 A RU2018135575 A RU 2018135575A RU 2018135575 A RU2018135575 A RU 2018135575A RU 2745844 C2 RU2745844 C2 RU 2745844C2
Authority
RU
Russia
Prior art keywords
nanocapsules
active ingredient
colloidal suspension
suspension according
vitamin
Prior art date
Application number
RU2018135575A
Other languages
English (en)
Russian (ru)
Other versions
RU2018135575A (ru
RU2018135575A3 (enExample
Inventor
Дамьен ПРЕВЕРО
Вероник РОЗИЛЬО
Original Assignee
Адиссео Франс С.А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56263861&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2745844(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Адиссео Франс С.А.С. filed Critical Адиссео Франс С.А.С.
Publication of RU2018135575A publication Critical patent/RU2018135575A/ru
Publication of RU2018135575A3 publication Critical patent/RU2018135575A3/ru
Application granted granted Critical
Publication of RU2745844C2 publication Critical patent/RU2745844C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Colloid Chemistry (AREA)
  • Fodder In General (AREA)
  • General Preparation And Processing Of Foods (AREA)
RU2018135575A 2016-03-25 2017-03-17 Нанокапсулы жирорастворимого активного ингредиента, их производство и виды применения RU2745844C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR16/52592 2016-03-25
FR1652592 2016-03-25
PCT/FR2017/050622 WO2017162963A1 (fr) 2016-03-25 2017-03-17 Nanocapsules de principe actif liposoluble, fabrication et utilisations

Publications (3)

Publication Number Publication Date
RU2018135575A RU2018135575A (ru) 2020-04-27
RU2018135575A3 RU2018135575A3 (enExample) 2020-06-09
RU2745844C2 true RU2745844C2 (ru) 2021-04-01

Family

ID=56263861

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018135575A RU2745844C2 (ru) 2016-03-25 2017-03-17 Нанокапсулы жирорастворимого активного ингредиента, их производство и виды применения

Country Status (14)

Country Link
US (1) US10765639B2 (enExample)
EP (1) EP3432729B1 (enExample)
JP (1) JP2019513359A (enExample)
KR (1) KR20180128025A (enExample)
CN (1) CN108882729A (enExample)
AU (1) AU2017236312B2 (enExample)
BR (1) BR112018069392B1 (enExample)
CA (1) CA3017931C (enExample)
ES (1) ES3040905T3 (enExample)
MX (1) MX2018011620A (enExample)
RU (1) RU2745844C2 (enExample)
UA (1) UA127243C2 (enExample)
WO (1) WO2017162963A1 (enExample)
ZA (1) ZA201806197B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102370217B1 (ko) * 2019-11-27 2022-03-07 군산대학교 산학협력단 유자 오일을 포함하는 나노복합체의 제조방법
RU2736051C1 (ru) * 2020-03-04 2020-11-11 Александр Александрович Кролевец Способ получения нанокапсул сухого экстракта эхинацеи
RU2743010C1 (ru) * 2020-03-23 2021-02-12 Таисия Скандарбековна Гутнова Способ получения нанокапсул витамина D3
CN114847488A (zh) * 2022-05-17 2022-08-05 江南大学 一种高稳定性和生物可给率的橘味维生素a-维生素d纳米复合载体制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1018363A1 (fr) * 1999-01-05 2000-07-12 L'oreal Nanoémulsion à base de copolymères blocs d'oxyde d'éthylène et d'oxde de propylène, et ses utilisations dans les domaines cosmétique, dermatologique et/ou phtalmologique
EP1552820A1 (fr) * 2004-01-09 2005-07-13 L'oreal Dispersion aqueuse de nanocapsules à coeur huileux et son procédé de fabrication
FR2924943A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition dermatologique comprenant des nanocapsules polymeriques de calcitriol, son procede de preparation et son utilisation
US20120202694A1 (en) * 2009-04-24 2012-08-09 Aaron Dodd Production of encapsulated nanoparticles at commercial scale
RU2557900C1 (ru) * 2014-03-25 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул витаминов

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803203B1 (fr) 1999-12-31 2002-05-10 Fournier Ind & Sante Nouvelles formulations galeniques du fenofibrate
FR2806005B1 (fr) * 2000-03-10 2002-06-14 Univ Claude Bernard Lyon Procede de preparation de particules colloidales sous forme de nanocapsules
FR2814380B1 (fr) * 2000-09-25 2002-11-08 Serobiologiques Lab Sa Poudre de microcapsules et procede d'obtention
JP2005028559A (ja) * 2003-07-08 2005-02-03 Shinobu Ito ナノカプセル
WO2007046632A1 (en) * 2005-10-18 2007-04-26 Amorepacific Corporation Cationic polymer nanoparticles encapsulating an active ingredients, and the cosmetic composition containing the same
PT1834635E (pt) 2006-03-13 2011-10-13 Advanced In Vitro Cell Technologies S L Sistemas estáveis de nanocápsula para a administração de moléculas activas
BRPI0805854A2 (pt) 2008-10-10 2010-08-24 Biolab Sanus Farmaceutica Ltda sistema nanoparticulado, processo de preparaÇço do mesmo, uso do mesmo, composiÇço fotoproterora, processo de preparaÇço da mesma, mÉtodo de prevenÇço de doenÇas e distérbios da pele
EP2266546A1 (en) * 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Process for the preparation of colloidal systems for the delivery of active compounds
ES2351756B1 (es) * 2009-07-28 2011-10-05 Universidad Del Pais Vasco Nanopartículas lipídicas para terapia génica.
CA2843943A1 (en) * 2014-02-20 2014-05-28 Pankaj Modi Oral formulations of chemotherapeutic agents
US10391060B2 (en) * 2015-08-06 2019-08-27 Rubicon Research Private Limited Particulate delivery systems

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1018363A1 (fr) * 1999-01-05 2000-07-12 L'oreal Nanoémulsion à base de copolymères blocs d'oxyde d'éthylène et d'oxde de propylène, et ses utilisations dans les domaines cosmétique, dermatologique et/ou phtalmologique
EP1552820A1 (fr) * 2004-01-09 2005-07-13 L'oreal Dispersion aqueuse de nanocapsules à coeur huileux et son procédé de fabrication
FR2924943A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition dermatologique comprenant des nanocapsules polymeriques de calcitriol, son procede de preparation et son utilisation
US20120202694A1 (en) * 2009-04-24 2012-08-09 Aaron Dodd Production of encapsulated nanoparticles at commercial scale
RU2557900C1 (ru) * 2014-03-25 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул витаминов

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OGAWA S. et al, Production and Characterization of O/W Emulsions Containing Droplets Stabilized by Lecithin-Chitosan-Pectin Mutilayered Membranes // J. Agric. Food Chem. 2004, 52, p.3595-3600. *

Also Published As

Publication number Publication date
BR112018069392A2 (pt) 2019-01-22
UA127243C2 (uk) 2023-06-21
JP2019513359A (ja) 2019-05-30
CA3017931C (fr) 2024-01-09
AU2017236312A1 (en) 2018-10-18
CA3017931A1 (fr) 2017-09-28
KR20180128025A (ko) 2018-11-30
RU2018135575A (ru) 2020-04-27
ES3040905T3 (en) 2025-11-05
RU2018135575A3 (enExample) 2020-06-09
US20190083414A1 (en) 2019-03-21
WO2017162963A1 (fr) 2017-09-28
EP3432729A1 (fr) 2019-01-30
EP3432729B1 (fr) 2025-08-13
MX2018011620A (es) 2019-03-14
AU2017236312B2 (en) 2021-02-04
ZA201806197B (en) 2019-06-26
BR112018069392B1 (pt) 2022-11-22
CN108882729A (zh) 2018-11-23
US10765639B2 (en) 2020-09-08

Similar Documents

Publication Publication Date Title
AU2008340061B2 (en) Microcapsules comprising a fat -soluble active substance
Talon et al. Encapsulation of eugenol by spray-drying using whey protein isolate or lecithin: Release kinetics, antioxidant and antimicrobial properties
CN106659230B (zh) 疏水性生物活性化合物的包封
CN109288065A (zh) 一种负载脂溶性维生素的悬浮乳液凝胶及其制备方法
JP6103258B2 (ja) 新規コーティングシステム
Hong et al. Retardation of curcumin degradation under various storage conditions via turmeric extract-loaded nanoemulsion system
Gómez-Guillén et al. Bioactive and technological functionality of a lipid extract from shrimp (L. vannamei) cephalothorax
US10765639B2 (en) Nanocapsules, methods of manufacture and uses thereof
WO2014135967A1 (en) Curcumin solid lipid particles and methods for their preparation and use
JP4934840B2 (ja) 脂溶性ビタミンないし脂溶性ビタミン様物質の油脂−糖質粉末素材及びその製造方法
JP6954917B2 (ja) 多相活性物質調製物
de Souza et al. Microencapsulation of sacha inchi oil using tannic acid, yeast cells and xanthan gum as wall materials
JP6464745B2 (ja) 生理活性物質の担持力を向上させたナノ粒子の製造方法
WO2008077401A1 (en) Reactive powdering
JP2011240221A (ja) 脂溶性機能性化合物エマルション及びその製造方法
JP2020105078A (ja) カロテン含有油性組成物
Liu et al. Anionic powdered-nanoliposome loaded with algal oil: Effects of carrier agents on storage stability, in-vitro digestibility and cellular uptake
JP6443009B2 (ja) 生理活性物質の担持力を向上させたナノ粒子の製造方法
RU2809106C2 (ru) Инкапсулированные пищевые и фармацевтические композиции
CN121102026A (zh) 一种用于活性物质可控递送的多重乳液及其制备方法与应用
JP2016124804A (ja) 天然物由来成分を基材とするナノ粒子の製造方法